Rhythm Pharmaceuticals (RYTM) Other Accumulated Expenses (2016 - 2025)
Rhythm Pharmaceuticals' Other Accumulated Expenses came in at $3.4 million for Q3 2025, down 90.7% from $36.64 million a year earlier and down 91.5% from the prior quarter.
Rhythm Pharmaceuticals (RYTM) Other Accumulated Expenses (2016 - 2025) Analysis & Trends
At the end of FY2024, Rhythm Pharmaceuticals' Other Accumulated Expenses was $37.7 million, up 596.9% from FY2023.
- Other Accumulated Expenses has increased in each of the last four years, with a five-year compound annual growth rate of 151.2% (FY2019 to FY2024).
- Going back by year, Other Accumulated Expenses was $5.41 million in FY2023 (+123.6%), $2.42 million in FY2022 (+202.4%), $800,000 in FY2021 (+344.4%) and $180,000 in FY2020 (-52.3%).
- The Q3 2025 figure represents the lowest quarterly Other Accumulated Expenses since Q2 2023.
- Year-over-year, Other Accumulated Expenses increased in seven of the last eight quarters, with growth averaging 346.9%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2024 (growth of 876.2%), and the weakest in Q3 2025 (a decline of 90.7%).
- Business Quant data shows RYTM's Other Accumulated Expenses at $40 million (Q2 2025), $38.78 million (Q1 2025) and $37.7 million (Q4 2024) in the three quarters before Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Rhythm Pharmaceuticals | 7.90 Bn | 6.52 Bn | 79.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | 38.78 Mn |
| Dec 31, 2024 | 37.70 Mn |
| Sep 30, 2024 | 36.64 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Mar 31, 2024 | 8.20 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 3.75 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.42 Mn |
| Sep 30, 2022 | 4.02 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 754,000.00 |
| Jun 30, 2021 | 341,000.00 |
| Mar 31, 2021 | 229,000.00 |
| Dec 31, 2020 | 180,000.00 |
Rhythm Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RYTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();